INTRODUCTION
Pemphigus vulgaris (PV) is an autoimmune bullous disease mediated by anti-desmoglein 3 (Dsg3) autoantibodies that are capable of directly causing acantholysis in the epidermis (Amagai et al., 1991 (Amagai et al., , 1992 Tsunoda et al., 2003; Payne et al., 2005) . The production of anti-Dsg3 autoantibodies in PV patients was shown to result from a functional collaboration between Dsg3-specific B and T cells (Nishifuji et al., 2000; Veldman et al., 2004b) , but recent accumulating evidence indicates that regulatory mechanisms play an important role in controlling the pathogenic autoimmune response (Kronenberg and Rudensky, 2005) . Potential cell types that modulate the autoimmune response include regulatory T cells, natural killer (NK) cells, and natural killer T cells. In this regard, Dsg3-specific T regulatory type 1 cells have the capacity to inhibit Dsg3-specific T helper type 2 (Th2) cells in vitro (Veldman et al., 2004a) . On the other hand, the roles of NK and natural killer T cells in the pathogenesis of PV have not been evaluated to date. NK cells have long been regarded as an essential component of innate immunity, because they exert nonspecific cytotoxic activity against virus-infected cells and tumor cells (Robertson and Ritz, 1990) . However, recent studies have revealed that NK cells are also the source of various cytokines, including both Th1 and Th2 cytokines (Warren et al., 1995; Mehrotra et al., 1998; Hoshino et al., 1999) , and they control the adaptive immune response by interacting directly with dendritic cells, T cells, and B cells (Blanca et al., 2001; Mailliard et al., 2003; Zingoni et al., 2004) . Natural killer T cells are also capable of producing large amounts of both Th1 and Th2 cytokines upon stimulation and thereby controlling the acquired immune response (Van Kaer, 2005) .
In this study, we investigated the involvement of these cell types and their potential regulatory functions in the autoimmune pathogenesis of PV, and found a unique Th2-biased property of NK cells.
RESULTS

Increased and activated circulating NK cells in PV patients
Flow cytometric analysis was performed to examine the proportions of lymphocyte subsets, including those with potential regulatory functions, such as naturally occurring CD4 þ CD25 high regulatory T cells, CD56 þ CD3 þ natural killer T cells, and CD56 þ CD3 À NK cells from 22 PV patients, including two with active disease, and from 28 healthy controls (Table 1) . A statistically significant difference was detected only for the proportion of NK cells (P ¼ 0.003). A representative flow cytometric finding for NK cells is shown in Figure 1a . Additional analyses of samples from 11 immune thrombocytopenic purpura (ITP) patients and 10 myasthenia gravis (MG) patients revealed that the increase in NK cells was unique to PV (Figure 1b) . The absolute number of circulating NK cells was also significantly increased in PV patients compared with healthy controls (P ¼ 0.03, Figure 1c ). We repeatedly assessed the NK cell proportion at different time points (interval 34-161 days) in four PV patients and three healthy controls, and found that the standard deviation of two sequential measurements was o4.0%.
We next evaluated the activation status of NK cells by examining the expression of CD69, a cell-surface marker expressed on activated NK cells (Marzio et al., 1999) . The proportion of CD69 þ -activated NK cells in PV patients was significantly increased compared with the proportion in ITP patients, MG patients, or healthy controls (Figure 1d ). These findings together indicate that NK cells were activated and expanded in the peripheral blood of PV patients.
Lack of difference in NK activity between PV patients and healthy controls
We assessed the NK activity in the peripheral blood mononuclear cell fraction from 14 PV patients and 12 healthy controls. NK cells from all the subjects showed cytotoxicity in an effector-to-target ratio-dependent manner. There was no statistically significant difference in the NK activity between PV patients and healthy controls (21.6714.3% vs 17.0710.5%), even though the proportion and activation status of the NK cells were higher in PV patients compared with healthy controls.
Upregulated expression of the IL-10 gene and downregulated expression of the IL-12Rb2, perforin, and granzyme B genes in NK cells from PV patients
To identify genes whose expression levels in NK cells were different between PV patients and healthy controls, we first carried out semi-quantitative PCR to evaluate the mRNA expression levels of 14 genes potentially involved in the regulatory function of NK cells, in NK cell preparations from four PV patients in remission, and four healthy controls (Table  S1 ). A significant difference in the gene expression level between these two groups was detected for IL-10, which was upregulated in PV patients and for the IL-12 receptor b2 (IL-12Rb2), perforin, and granzyme B, which were downregulated in PV patients, compared with healthy controls.
To confirm these findings, we used the TaqMan s PCR system to quantify the mRNA expression levels in a larger number of subjects: six PV patients with active disease, 13 PV patients in remission, and 11 healthy controls (Figure 2 ). The expression of IL-10 was again significantly higher, and the expression of IL-12Rb2, perforin, and granzyme B was significantly lower in PV patients in remission and with active disease, compared with healthy controls. There was no difference in the expression levels of these four genes between PV patients with active disease and those in remission.
Impaired IL-12 signaling in NK cells from PV patients
The decreased IL-12Rb2 gene expression in the NK cells from PV patients could potentially lead to impaired IL-12 signaling. To test this hypothesis, NK cells from five PV patients, including one with active disease, and five healthy controls were stimulated with IL-12 and examined for the (Jacobson et al., 1995) . Immunoblotting of the cellular lysates of IL-12-stimulated NK cells to detect phosphorylated and total Stat4 revealed that the degree of Stat4 phosphorylation was significantly lower in PV patients than in healthy controls (P ¼ 0.008; Figure 3 ).
Reduced IL-10 production from NK cells upon in vitro stimulation with IL-2 and IL-12 in PV patients
To confirm the upregulated IL-10 expression in NK cells from PV patients at a protein level, we measured IL-10 concentration in NK cell lysates using ELISA. However, IL-10 concentration was below the detection limit despite utilization of a highly sensitive commercial kit. NK cells were then stimulated with or without a combination of IL-2 and IL-12, a well-known stimulant for IL-10 production from NK cells In patients with multiple sclerosis, IL-5 expression by NK cells is upregulated in remission, but not in the active disease phase (Takahashi et al., 2001) . In contrast, we failed to detect IL-5 mRNA in the PV patients in remission (Table S1 ). When the NK cells from additional PV patients were examined, IL-5 mRNA expression was detected exclusively in the patient with active disease (Figure 5a ). The IL-5 expression by NK cells was further evaluated in 19 PV patients, including six with active disease, and 11 healthy controls using TaqMan s quantitative PCR (Figure 5b ). IL-5 mRNA expression was detected in four PV patients with active disease (67%), but in none of 13 PV patients in remission. Serial analysis in two PV patients with active disease revealed the loss of IL-5 expression after the disease became quiescent.
DISCUSSION
We demonstrate here that NK cells are quantitatively and phenotypically altered in PV patients as follows: (i) an increased proportion and absolute number of NK cells in circulation; (ii) an increased proportion of CD69
þ -activated cells; (iii) downregulated IL-12Rb2, perforin, and granzyme B genes; (iv) impaired IL-12-induced Stat4 phosphorylation; (v) upregulated expression of IL-10; (vi) reduced IL-10 production upon in vitro IL-2/IL-12 stimulation; and (vii) upregulated expression of IL-5 in association with active disease status.
The NK cells have been quantitatively analyzed in several autoimmune and inflammatory diseases. The majority of these diseases, including multiple sclerosis, Graves' disease, and psoriasis, are associated with a decreased proportion of NK cells (Kastrukoff et al., 1998; Rojano et al., 1998; Cameron et al., 2003) , but PV patients showed an increased proportion. In addition, the in vivo activation of NK cells appears to be unique to PV patients, because ITP patients and MG patients lacked this feature. Several lines of evidence indicate that NK cells control the fate of the autoimmune response. Specifically, the depletion of NK cells increases the severity of experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis, which is a welldocumented Th1-mediated autoimmune disease (Zhang et al., 1997) . In contrast, NK-cell depletion delays the onset of disease and diminishes the severity of experimental autoimmune MG, a model for autoantibody-mediated autoimmune disease (Shi et al., 2000) . These findings indicate that regulatory roles of NK cells in the pathogenic immune response are different among the autoimmune diseases.
NK cells reside not only in the peripheral blood, but also in the spleen and lymph nodes (Ferlazzo et al., 2004) , where the interaction between autoreactive T and B cells primarily occurs (Kuwana et al., 2002; Kent et al., 2005) . The recruitment of NK cells into the lymph nodes results in induction of the Th1 response by secretion of IFN-g (Martin- Fontecha et al., 2004) . In PV patients, circulating NK cells showed characteristic gene expression profiles, irrespective of the disease status, that is, downregulated IL-12Rb2 and upregulated IL-10. Because IL-12Rb2 is a key molecule in Th1 differentiation (Chan et al., 1991; Yoshida et al., 1994; Ma et al., 1996) , the downregulated IL-12Rb2 mRNA expression and impaired IL-12 signaling in NK cells observed in PV patients may lead to a reduced capacity to induce the Th1 response. Taken together with the upregulated expression of IL-10 mRNA, it is likely that NK cells contribute to a Th2-biased environment in PV patients. As one of the effects of IL-10 on B cells is to promote production of antibodies, especially of the IgG4 isotype (Jeannin et al., 1998) , the upregulated IL-10 expression in NK cells may result in the IgG4-dominant anti-Dsg3 autoantibody response observed in PV patients irrespective of the disease status (Jones et al., 1988; Shirakata et al., 1990; Wilson et al., 1993; Futei et al., 2001) .
In contrast to upregulated IL-10 mRNA expression ex vivo, NK cells from PV patients produced less IL-10 than did those from healthy controls upon in vitro IL-2/IL-12 stimulation. This phenomenon might be explained by impaired IL-12 signaling observed in NK cells from PV patients. In this case, in vivo IL-10 upregulation by NK cells in PV patients is potentially mediated through IL-12-independent pathway. Alternatively, NK cells are already activated and exhausted in vivo in PV patients.
We also found an upregulated expression of IL-5, another Th2 cytokine, exclusively in PV patients with active disease. Interestingly, this pattern of IL-5 expression in NK cells in association with the disease status is completely opposite to that seen in multiple sclerosis patients, in whom IL-5 is upregulated in remission, but downregulated in the active phase (Takahashi et al., 2001) . Distinct gene expression controls by the NK cells in PV and multiple sclerosis might reflect a difference in the role of Th1/Th2 balance in the disease pathogenesis. As IL-5-producing NK cells inhibit the Th1 response and drive Th2 polarization (Takahashi et al., 2001) , the expression of IL-5 by NK cells in patients with active PV further enhances the Th2-biased environment. This might also explain why IgE anti-Dsg3 antibodies are detected in PV patients with active disease, but not in those in remission (Spaeth et al., 2001) , because IL-5 is known to enhance IgE secretion (Pene et al., 1988; Vercelli et al., 1989) .
In summary, our findings suggest that NK cells may be involved in the pathogenic autoimmune response in PV patients by promoting Th2 polarization, although additional studies using serial samples collected before and after the initiation of the treatment are necessary to confirm our theory.
MATERIALS AND METHODS
Patients and controls
We studied 28 patients (12 men) with PV that were diagnosed on the basis of all the following findings: (1) suprabasal acantholysis by histological examination; (2) IgG deposition on the keratinocyte cell surfaces by direct immunofluorescence; and (3) a positive test for serum IgG anti-Dsg3 antibody. The average age at examination was www.jidonline.org 327 H Takahashi et al.
Th2-Biased NK Cell Phenotype in PV 51.0710.8 years. Nine patients (32%) had additional IgG anti-Dsg1 antibody. At the time of blood sample collection, six patients had active disease, and the remaining 22 were in clinical remission, defined as having had no bullae or erosions during the past 2 months, irrespective of treatment.
We also examined 11 patients (two men) with ITP and 10 (two men) with MG to control for autoantibody-mediated autoimmune disease. The average age at examination of the ITP patients and MG patients was 53.7719.2 and 53.5718.4 years, respectively. The diagnoses of ITP and MG were based on the published criteria (Drachman, 1994; George et al., 1996) . Thirty-five healthy individuals (13 men) were also used as control subjects, and their average age at examination was 47.5720.1 years. There was no statistically significant difference in sex distribution or age at examination between the PV patient group and the individual control groups. Twenty-two PV patients (76%), four ITP patients (36%), and six MG patients (60%) were taking low-dose prednisolone at the time of blood collection, and the mean daily dosage was 9.3 mg (range 1-19 mg), 8.1 mg (5-10 mg), and 5.8 mg (3-10 mg), respectively. This study was approved by the Keio University Institutional Review Board and conducted according to the Declaration of Helsinki Principles. Written informed consent was obtained from all the subjects.
Flow cytometric analysis
Peripheral blood mononuclear cells were incubated with fluorescence-conjugated mouse monoclonal antibodies, including anti-CD3-FITC, anti-CD4-FITC, anti-CD8-phycoerythrin, anti-CD56-phycoerythrin, anti-CD69-phycoerythrin-cyanin 5.1 (Beckman-Coulter, Hialeah, FL), and anti-CD19-Cy-Chrome (Becton Dickinson, San Diego, CA), followed by analysis with a FACSCalibur s flow cytometer (Becton Dickinson). All analyses were performed on the lymphocyte fraction gated based on the forward and side scatters. The absolute number of the cells of interest was quantified as the number per 1 ml of peripheral blood, based on the ratio to the number of FlowCount s microbeads (Beckman-Coulter). Appropriate fluorescence-labeled isotype-matched control antibodies were included in all the analyses.
NK activity
The nonspecific cytotoxic activity of NK cells was measured by the 51 Cr release assay according to a previously described method (Lanier et al., 1983) with some modifications. Briefly, 51 Cr-labeled target cells (leukemia cell line K562) were mixed with freshly isolated peripheral blood mononuclear cells at effector-to-target ratios of 1:1, 5:1, 10:1, and 20:1 for 4 hours, and the radioactivity released into the culture supernatants was measured using an automatic gamma counter (Perkin-Elmer Life Sciences, Boston, MA). Each assay was performed in triplicate, and the percent lysis was calculated using the following formula: (experimental release Àspontaneous release)/(maximal release in the presence of 1% Triton XÀspontaneous release) Â 100. NK activity was defined as the percent lysis at an effector-to-target ratio of 20:1.
Isolation of NK cells
NK cells were highly purified by a two-step sorting process using a MACS cell isolation system (Miltenyi Biotech, Bergisch Galdbach, Germany 
Analysis of mRNA expression
Sorted NK cells were used to determine semi-quantitatively their mRNA expression levels of 14 genes (listed in Table S2 ) that are potentially associated with NK cell function. In brief, total RNA was isolated using an RNeasy mini kit (Qiagen, Hilden, Germany), and treated with AMV RTase XL (TAKARA BIO, Otsu, Japan) in the presence of an oligo-dT primer to generate first-strand cDNA. The cDNA equivalent to 5 ng total RNA was subjected to PCR under the conditions shown in Table S2 . The number of PCR cycles was adjusted to assure that the correlation between the amplified product and the amount of input cDNA fell within a linear range. The PCR products were then fractionated on agarose gels and visualized by ethidium bromide staining. The intensity of individual bands that corresponded to the expected molecular size was semi-quantified using NIH Image s available at http://rsb.info.nih.gov/nih-image/. The relative mRNA expression level was normalized to the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The mRNA expression of the selected genes was further analyzed quantitatively using a Taqman s real-time PCR system with an ABI PRISM s 7900HT (Applied Biosystems, Foster City, CA). cDNA equivalent to 10 ng total RNA was subjected in duplicate to the reactions according to the manufacturer's protocol. Primer pairs and a TaqMan probe for perforin, granzyme B, IL-5, and GAPDH were purchased from Applied Biosystems, whereas those for IL-10 and IL-12Rb2 were designed using Primer Express s Software v2.0 (Applied Biosystems) as follows: IL-10, sense (5 0 -GGCGCTGTCATCGA
probe (5 0 -CAAGAGCAAGGCCGTGGAGCAGG-3 0 ); and IL-12Rb2,
. The gene expression was standardized on the basis of serial dilutions of cDNA prepared from a healthy individual's peripheral blood mononuclear cells that were stimulated with phorbol 12-myrisate 13-acetate (25 ng/ml) and ionomycin (1 mg/ml) (Sigma, St Louis, MO). Relative expression levels were normalized to the expression level of GAPDH.
Evaluation of phosphorylated Stat4 in NK cells
The phosphorylation status of Stat4 in NK cells was evaluated as described previously (Toyoda et al., 2004) . Briefly, sorted NK cells were incubated with rIL-12 (50 ng/ml; R&D systems, Minneapolis, MN) at 371C for 30 minutes. The soluble fraction derived from 10 5 cells was fractionated by SDS-7.5% polyacrylamide gel electrophoresis, and subjected to immunoblotting using the Can Get Signal system (TOYOBO, Osaka, Japan) with rabbit anti-phosphorylated Stat4 polyclonal antibodies (Zymed Laboratories, South San Francisco, CA) and peroxidase-conjugated anti-rabbit IgG antibodies (Cappel, Aurora, OH). The antibodies that bound to the membrane were subsequently visualized using Western Lightning TM Chemiluminescence Reagent Plus (Perkin-Elmer Life Sciences, Boston, MA). After a stripping treatment with Restore TM Western Blot Stripping Buffer (Pierce, Rockford, IL), the membrane was re-subjected to immunoblotting using rabbit anti-Stat4 polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). The intensity of individual bands was semi-quantitatively assessed using NIH Image s . The degree of phosphorylation was evaluated as the ratio of the intensity of phosphorylated Stat4 to that of total Stat4.
Quantification of IL-10 production by NK cells
To quantify IL-10 in freshly isolated NK cells, soluble fractions derived from NK cells (10 6 cells) were subjected to highly sensitive ELISA (Quantikine s HS; R&D systems) (sensitivity 0.5 pg/ml). To evaluate IL-10 produced by NK cells upon in vitro stimulation, NK cells (10 5 /well) were cultured in 96-well flat-bottomed plates with or without a combination of rIL-12 (10 ng/ml) and rIL-2 (100 U/ml; Shionogi, Osaka, Japan) for 3 days. Culture supernatants were harvested and IL-10 concentrations were measured by BD OptEIA Human IL-10 ELISA (BD, Franklin Lakes, NJ) (sensitivity 2.0 pg/ml).
Statistical analysis
All comparisons for statistical differences between two patient groups were performed using the Fisher's two-tailed exact test or Mann-Whitney U-test as appropriate.
